Diverse roles of mitochondria in ischemic stroke

Stroke is the leading cause of adult disability and mortality in most developing and developed countries. The current best practices for patients with acute ischemic stroke include intravenous tissue plasminogen activator and endovascular thrombectomy for large-vessel occlusion to improve clinical o...

Full description

Bibliographic Details
Main Authors: Jenq-Lin Yang, Sujira Mukda, Shang-Der Chen
Format: Article
Language:English
Published: Elsevier 2018-06-01
Series:Redox Biology
Online Access:http://www.sciencedirect.com/science/article/pii/S2213231718300570
_version_ 1819104451708846080
author Jenq-Lin Yang
Sujira Mukda
Shang-Der Chen
author_facet Jenq-Lin Yang
Sujira Mukda
Shang-Der Chen
author_sort Jenq-Lin Yang
collection DOAJ
description Stroke is the leading cause of adult disability and mortality in most developing and developed countries. The current best practices for patients with acute ischemic stroke include intravenous tissue plasminogen activator and endovascular thrombectomy for large-vessel occlusion to improve clinical outcomes. However, only a limited portion of patients receive thrombolytic therapy or endovascular treatment because the therapeutic time window after ischemic stroke is narrow. To address the current shortage of stroke management approaches, it is critical to identify new potential therapeutic targets. The mitochondrion is an often overlooked target for the clinical treatment of stroke. Early studies of mitochondria focused on their bioenergetic role; however, these organelles are now known to be important in a wide range of cellular functions and signaling events. This review aims to summarize the current knowledge on the mitochondrial molecular mechanisms underlying cerebral ischemia and involved in reactive oxygen species generation and scavenging, electron transport chain dysfunction, apoptosis, mitochondrial dynamics and biogenesis, and inflammation. A better understanding of the roles of mitochondria in ischemia-related neuronal death and protection may provide a rationale for the development of innovative therapeutic regimens for ischemic stroke and other stroke syndromes. Keywords: Mitochondria, Ischemic stroke, Apoptosis, Mitochondrial biogenesis, Mitochondrial dynamics, Mitophagy, Inflammation
first_indexed 2024-12-22T02:06:34Z
format Article
id doaj.art-5818bae3581d4df3a9088301ad329d32
institution Directory Open Access Journal
issn 2213-2317
language English
last_indexed 2024-12-22T02:06:34Z
publishDate 2018-06-01
publisher Elsevier
record_format Article
series Redox Biology
spelling doaj.art-5818bae3581d4df3a9088301ad329d322022-12-21T18:42:30ZengElsevierRedox Biology2213-23172018-06-0116263275Diverse roles of mitochondria in ischemic strokeJenq-Lin Yang0Sujira Mukda1Shang-Der Chen2Institute for Translation Research in Biomedicine, Kaohsiung Chang Gung Memorial Hospital, 123 Dapi Road, Kaohsiung 83301, Taiwan, ROCInstitute for Translation Research in Biomedicine, Kaohsiung Chang Gung Memorial Hospital, 123 Dapi Road, Kaohsiung 83301, Taiwan, ROC; Research Center for Neuroscience, Institute of Molecular Biosciences, Mahidol University, 25/25 Phuttamonthon 4 Road, Salaya, Nakhon Pathom 73170, ThailandInstitute for Translation Research in Biomedicine, Kaohsiung Chang Gung Memorial Hospital, 123 Dapi Road, Kaohsiung 83301, Taiwan, ROC; Department of Neurology, Kaohsiung Chang Gung Memorial Hospital, 123 Dapi Road, Kaohsiung 83301, Taiwan, ROC; College of Medicine, Chang Gung University, 259 Wenhua 1st Road, Taoyuan 33302, Taiwan, ROC; Corresponding author at: Department of Neurology and Institute for Translation Research in Biomedicine, Kaohsiung Chang Gung Memorial Hospital, 123 Dapi Road, Kaohsiung 83301, Taiwan.Stroke is the leading cause of adult disability and mortality in most developing and developed countries. The current best practices for patients with acute ischemic stroke include intravenous tissue plasminogen activator and endovascular thrombectomy for large-vessel occlusion to improve clinical outcomes. However, only a limited portion of patients receive thrombolytic therapy or endovascular treatment because the therapeutic time window after ischemic stroke is narrow. To address the current shortage of stroke management approaches, it is critical to identify new potential therapeutic targets. The mitochondrion is an often overlooked target for the clinical treatment of stroke. Early studies of mitochondria focused on their bioenergetic role; however, these organelles are now known to be important in a wide range of cellular functions and signaling events. This review aims to summarize the current knowledge on the mitochondrial molecular mechanisms underlying cerebral ischemia and involved in reactive oxygen species generation and scavenging, electron transport chain dysfunction, apoptosis, mitochondrial dynamics and biogenesis, and inflammation. A better understanding of the roles of mitochondria in ischemia-related neuronal death and protection may provide a rationale for the development of innovative therapeutic regimens for ischemic stroke and other stroke syndromes. Keywords: Mitochondria, Ischemic stroke, Apoptosis, Mitochondrial biogenesis, Mitochondrial dynamics, Mitophagy, Inflammationhttp://www.sciencedirect.com/science/article/pii/S2213231718300570
spellingShingle Jenq-Lin Yang
Sujira Mukda
Shang-Der Chen
Diverse roles of mitochondria in ischemic stroke
Redox Biology
title Diverse roles of mitochondria in ischemic stroke
title_full Diverse roles of mitochondria in ischemic stroke
title_fullStr Diverse roles of mitochondria in ischemic stroke
title_full_unstemmed Diverse roles of mitochondria in ischemic stroke
title_short Diverse roles of mitochondria in ischemic stroke
title_sort diverse roles of mitochondria in ischemic stroke
url http://www.sciencedirect.com/science/article/pii/S2213231718300570
work_keys_str_mv AT jenqlinyang diverserolesofmitochondriainischemicstroke
AT sujiramukda diverserolesofmitochondriainischemicstroke
AT shangderchen diverserolesofmitochondriainischemicstroke